Literature DB >> 11390024

A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat.

T A Hamilton1, R K Handa, J W Harding, J W Wright.   

Abstract

Angiotensin II (AngII) or Angiotensin IV (AngIV) was infused into the renal artery of anesthetized rats while renal cortical blood flow was measured via laser Doppler flowmetry. The infusion of AngII produced a significant elevation in mean arterial pressure (MAP) with an accompanying decrease in cortical blood flow, glomerular filtration rate (GFR), urine volume, and urine sodium excretion. The infusion of AngIV induced significant increases in renal cortical blood flow and urine sodium excretion, without altering MAP, GFR, and urine volume. Pretreatment infusion with a specific AT1 receptor antagonist, DuP 753, blocked or attenuated the subsequent AngII effects, while pretreatment infusion with the specific AT4 receptor antagonist, Divalinal-AngIV, blocked the AngIV effects. These results support distinct and opposite roles for AngII and AngIV, i.e. AngII acts as an anti-natriuretic agent, while AngIV acts as a natriuretic agent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390024     DOI: 10.1016/s0196-9781(01)00405-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  12 in total

Review 1.  The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Authors:  John W Wright; Joseph W Harding
Journal:  Pflugers Arch       Date:  2012-04-26       Impact factor: 3.657

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

3.  Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS/MS: metabolism by bovine adrenal endothelial cells.

Authors:  Lijie Cui; Kasem Nithipatikom; William B Campbell
Journal:  Anal Biochem       Date:  2007-07-05       Impact factor: 3.365

Review 4.  Role of central and peripheral aminopeptidase activities in the control of blood pressure: a working hypothesis.

Authors:  Manuel Ramírez; Isabel Prieto; Francisco Alba; Francisco Vives; Inmaculada Banegas; Marc de Gasparo
Journal:  Heart Fail Rev       Date:  2008-03-29       Impact factor: 4.214

Review 5.  The role of angiotensin II receptors in stroke protection.

Authors:  Steven G Chrysant
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 6.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

7.  Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways.

Authors:  Panayiota Koupepidou; Kyriacos N Felekkis; Bettina Kränzlin; Carsten Sticht; Norbert Gretz; Constantinos Deltas
Journal:  BMC Nephrol       Date:  2010-09-02       Impact factor: 2.388

Review 8.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

9.  The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system.

Authors:  Caroline C Benoist; Leen H Kawas; Mingyan Zhu; Katherine A Tyson; Lori Stillmaker; Suzanne M Appleyard; John W Wright; Gary A Wayman; Joseph W Harding
Journal:  J Pharmacol Exp Ther       Date:  2014-09-03       Impact factor: 4.030

Review 10.  Angiotensin II revisited: new roles in inflammation, immunology and aging.

Authors:  Ariela Benigni; Paola Cassis; Giuseppe Remuzzi
Journal:  EMBO Mol Med       Date:  2010-07       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.